Deep Vein Thrombosis in Obstetric Patients: Diagnosis and Risk Factors

Summary

This study was performed to assess the prevalence of deep vein thrombosis (DVT) in consecutive obstetric patients with clinical symptoms of DVT, using impedance plethysmography (IPG) as the diagnostic method and to establish the safety of withholding anticoagulant therapy in patients with a repeatedly normal IPG. In addition, in patients with DVT the prevalence of coagulation and fibrinolytic disorders, which may explain the occurrence of venous thrombosis was investigated.Of the 77 obstetric patients with symptoms of DVT 32 (42%) had an abnormal IPG. The remaining 45 patients had a repeatedly normal IPG and showed no venous thromboembolism during a 6 months follow-up period. Twenty percent (six patients) of the patients with an abnormal IPG had a coagulation or fibrinolytic abnormality. These observations suggest that serial IPG can be used effectively in the management of obstetric patients with clinically suspected DVT and that hemostatic abnormalities are frequently found in those patients with DVT

• References

• 1 Kierkegaard A. Incidence and diagnosis of deep vein thrombosis associated with pregnancy. Acta Obstet Gynecol Scand 1983; 62: 239-243
• 2 Rochat RW, Koonin LM, Atrash HK, Jewett JF. and the maternal mortality collaborative Maternal mortality in the United States. Report from the maternal mortality collaborative. Obstet Gynecol 1988; 72: 91-97
• 3 Huisman MV, Biiller HR, ten Cate JW, Vreeken J. Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. N Engl J Med 1986; 314: 823-828
• 4 Hull RD, Hirsh J, Carter CJ. et al. Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. Ann Intern Med 1985; 102: 21-22
• 5 Hull RD, Raskob GE, Carter CJ. Serial impedance plethysmography in pregnant patients with clinically suspected deep-vein thrombosis. Ann Intern Med 1990; 112: 663-667
• 6 Conard J, Horrelou MH, van Dreden P, Lecompte T, Samama A. Thrombosis and pregnancy in congenital deficiencies in AT III, protein C, or protein S: Study of 78 women. Thromb Haemostas 1990; 63: 319-320
• 7 Huisman MV, Biiller HR, ten Cate JW. Utility of impedance plethysmography in the diagnosis of recurrent deep-vein thrombosis. Arch Intern Med 1988; 148: 681-683
• 8 Hull R, van Aken WG, Hirsh J. et al Impedance plethysmography: The relationship between venous filling and sensitivity and specificity for proximal venous thrombosis. Circulation 1978; 58: 898-902
• 9 Levi M, ten Cate JW, Dooijewaard G, Sturk A, Brommer E, Agnelli G. DDAVP induces systemic release of urokinase-type plasminogen activator. Thromb Haemostas 1989; 62: 686-689
• 10 Thomson J. Hereditary coagulation disorders, laboratory techniques. In: Blood Coagulation and Haemostasis. Thomson J. (ed). Churchill Livingstone; Edinburgh: 1980. pp 117-157
• 11 Alving BM, Baldwin PE, Richards RL, Jackson BJ. The dilute phospholipid APTT: A sensitive assay for verification of lupus anticoagulants. Thromb Haemostas 1985; 54: 709-712
• 12 Peters M, Breederveld C, Kahlé L, ten Cate JW. Rapid microanalysis of coagulation parameters by automated chromogenic substrate methods, application in neonatal patients. Thromb Res 1982; 28: 773-781
• 13 Sturk A, Morriën-Salomons WM, Huisman MV, Borm JJJ, Biiller HR, teny Cate JW. Analytical and clinical evaluation of commercial protein C assays. Clin Chim Acta 1987; 165: 263-270
• 14 Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of a fast acting inhibitor of tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51: 392-395
• 15 Holvoet P, Cleemput H, Collen D. Assay of human tissue-type plasminogen activator (t-PA) with an enzyme linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PA. Thromb Haemostas 1985; 54: 684-687
• 16 Binnema DJ, van Iersel JJL, Dooijewaard G. Quantitation of urokinase antigen in plasma and culture media by use of an ELISA. Thromb Res 1986; 43: 569-577
• 17 Levi M, Lensing AWA, Biiller HR. et al Deep vein thrombosis and fibrinolysis. Defective urokinase type plasminogen activator release. Thromb Haemostas 1991; 66: 426-429
• 18 Haeger K. Problems of acute deep venous thrombosis. I. The interpretation of signs and symptoms. Angiology 1969; 20: 219-223
• 19 Bergqvist D, Hedner U. Pregnancy and venous thromboembolism. Acta Obstet Gynecol Scand 1983; 62: 449-453
• 20 Clarke Pearson DL, Jelorsek FR. Alterations of occlusive cuff impedance plethysmography results in the obstetric patient. Surgery 1981; 98: 594-598
• 21 Ginsberg JS, Hirsh J, Rainbow AJ, Coates G. Risks to the fetus of radiologic procedures used in the diagnosis of maternal venous thromboembolic disease. Thromb Haemostas 1989; 61: 189-196
• 22 Lensing AWA, Prandoni P, Biiller HR, Cogo A, Canova B, ten Cate JW. Abnormality of coagulation factors and fibrinolysis in deep-vein thrombosis. Thromb Haemostas 1989; 62: 444 (Abstr)
• 23 Heijboer H, Brandjes DPM, Sturk A, Biiller HR, ten Cate JW. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. N Engl J Med 1990; 323: 1512-1516
• 24 Han P, Koay ESC, Tsakok M, Aw TC, Wong LY, Pradhan M. Altered fibrinolysis in DVT: Influence of site of sampling. Thromb Haemostas 1988; 60: 50-53